1. Home
  2. Stock quotes
  3. Revance Therapeutics
  4. Financial Statements
  5. Income Statement
  6. General and Administrative Expenses
Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.86 1.45%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics General and Administrative Expenses 2011-2024 | RVNC

Annual General and Administrative Expenses Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
298 M 224 M 199 M 152 M 62 M 53.9 M 37.4 M 29.1 M 25.1 M 19 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
298 M 19 M 110 M

Quarterly General and Administrative Expenses Revance Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
62.6 M 65.8 M 68.9 M - 65.8 M 74.8 M 61.9 M - 65.8 M 47.8 M 45.1 M - 52.8 M 50.6 M 49 M - 48.2 M 29.6 M 21.2 M - 16.7 M 13.6 M 12.9 M - 14.2 M 12.7 M 13.6 M - 9.15 M 8.61 M 7.75 M - 7.5 M 7.02 M 7.46 M - 5.83 M 6.36 M 6 M - 5.3 M 4.86 M 4.09 M - 2.14 M 3.64 M 2.22 M - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
74.8 M 2.14 M 27.3 M